SCHEMBL29494537

SCHEMBL29494537

CC(=O)Nc1ccc(C)c(C(=O)NCc2cccc3ncccc23)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CLK1 P49759 1/20 0.52
▸ BLK P51451 1/20 0.50
▸ NSD2 O96028 1/20 0.49
▸ ACLY P53396 1/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ ADORA2A P29274 1/20 0.45
▸ ADORA1 P30542 1/20 0.45
▸ DGAT2 Q96PD7 1/20 0.44
▸ BCHE P06276 1/20 0.44
▸ ROCK1 Q13464 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ MAPK8 P45983 1/20 0.42
▸ MAPK9 P45984 1/20 0.42
▸ MAPK10 P53779 1/20 0.42
▸ KCNH2 Q12809 1/20 0.42
▸ KCNB1 Q14721 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29494507 0.91 BLK (0.52) CLK1BLKNSD2ACLYMEN1
SCHEMBL29494461 0.89 BLK (0.50) CLK1BLKNSD2ACLYMEN1
SCHEMBL29494528 0.85 BLK (0.47) BLKNSD2ACLYMEN1KMT2A
SCHEMBL29494530 0.75 NPC1 (0.51) MEN1KMT2ASMN1; SMN2BCHEKCNH2
SCHEMBL3235212 0.74 MTNR1A (0.54) MEN1KMT2A
SCHEMBL29494496 0.72 MAPT (0.50) MEN1KMT2ASMN1; SMN2ADORA1ALDH1A1
SCHEMBL23715750 0.70 ALDH1A1 (0.61) CLK1MEN1KMT2ASMN1; SMN2MAPK8
SCHEMBL30874538 0.70 MEN1 (0.54) NSD2MEN1KMT2ASMN1; SMN2CYP2C9
SCHEMBL29191075 0.70 MEN1 (0.54) NSD2MEN1KMT2ASMN1; SMN2CYP2C9
SCHEMBL27382838 0.68 ADORA2A (0.61) ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022070048-A1 NOVEL AMIDE DERIVATIVES CADILA HEALTHCARE LIMITED (IN) 2022-04-07 — — WO disclosed
Send feedback